Design Therapeutics
DSGN
DSGN
87 hedge funds and large institutions have $77.6M invested in Design Therapeutics in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 38 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
29% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 38
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
68% less capital invested
Capital invested by funds: $244M → $77.6M (-$167M)
Holders
87
Holding in Top 10
1
Calls
$263K
Puts
$299K
Top Buyers
| 1 | +$5.27M | |
| 2 | +$3.19M | |
| 3 | +$2.84M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.42M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$2.36M |
Top Sellers
| 1 | -$32.4M | |
| 2 | -$22.1M | |
| 3 | -$18.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$5.23M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.16M |